2023 annual financial data
Dogwood Therapeutics 2023 Net margin
Direct answer
Net margin was Not calculable.
Operating income was -5,446,919 USD and net income was -5,296,015 USD.
Operating cash flow was -4,870,489 USD.
Get free Dogwood Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -5,446,919 USD
- Net income
- -5,296,015 USD
- Operating cash flow
- -4,870,489 USD
Explore related company data
View all 2023 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Dogwood Therapeutics financial years